Demographic and clinical characteristics of patients with SARS-CoV-2 infection
DOI:
https://doi.org/10.51481/amc.v63i4.1126Keywords:
Covid-19, Coronavirus Infections, pneumonia, mortalityAbstract
Background: The SARS-CoV-2 pandemic has had a strong international and national impact. The Intensive Care Unit of the Dr. R.A. Calderón Guardia Hospital has received critically ill patients with COVID-19 since March 2020. The purpose of this study was to describe the main clinical and evolution characteristics of this population.
Methods: This is a descriptive, observational study covering a 7-month period from March to September 2020. Information was taken from 2 ICU databases, one of which was designed for this purpose.
Results: Information was collected from 120 patients, 91 (76%) male with a mean age of 60 years, mean mortality was similar for men and women standing at 52%. The population was primarily overweight or obese with an average body mass index of 31.3.
Eighty-one patients (67.5%) required mechanical ventilation and 72 patients (60%) developed acute renal failure. Mechanical ventilation increased the risk of death by 14.7 times and renal injury by 10.6 times.
Approximately half of the patients developed at least one nosocomial infection.
Conclusion: Severe SARS-CoV-2 infection has a high morbidity and mortality burden and is frequently associated with increased ventilatory requirements and renal failure. The latter two conditions significantly increase the risk of death.
Downloads
References
Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Vol. 76, International Journal of Surgery. 2020.
Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: An overview. Vol. 83, Journal of the Chinese Medical Association. 2020.
Kannan S, Ali PSS, Sheeza A, Hemalatha K. COVID-19 (Novel Coronavirus 2019) - recent trends. Eur Rev Med Pharmacol Sci. 2020;24(4).
Presidencia de la República. Reforma Declara estado de emergencia nacional en todo el territorio de la República de Costa Rica, debido a la situación de emergencia sanitaria provocada por la enfermedad COVID-19 N° 42296-MP-S [Internet]. Diario Oficial La Gaceta; 2020. Available from: http://www.pgrweb.go.cr/scij/Busqueda/Normativa/Normas/nrm_texto_completo.aspx?param1=NRTC&nValor1=1&nValor2=91036&nValor3=120113&strTipM=TC
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Vol. 109, Journal of Autoimmunity. 2020.
Velavan TP, Meyer CG. The COVID-19 epidemic. Vol. 25, Tropical Medicine and International Health. 2020.
Bajgain KT, Badal S, Bajgain BB, Santana MJ. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature. Am J Infect Control [Internet]. 2021;49(2):238-46. Available from: https://doi.org/10.1016/j.ajic.2020.06.213
Petrilli CM, Jones SA, Yang J, Rajagopalan H, O'Donnell L, Chernyak Y, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: Prospective cohort study. BMJ. 2020;369.
Busetto L, Bettini S, Fabris R, Serra R, Dal Pra C, Maffei P, et al. Obesity and COVID-19: An Italian Snapshot. Obesity. 2020;28(9):1600-5.
Tang X, Du RH, Wang R, Cao TZ, Guan LL, Yang CQ, et al. Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1. Chest. 2020;158(1).
Chan L, Hindi J, Nadkarni GN. COVID-19: The Kidneys Tell a Tale. Am J Kidney Dis [Internet]. 2021;77(2):175-7. Available from: https://doi.org/10.1053/j.ajkd.2020.11.001
Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Zhao S, et al. AKI in hospitalized patients with COVID-19. J Am Soc Nephrol. 2021;32(1):151-60.
Published
Issue
Section
License
Copyright (c) 2022 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
